tiprankstipranks
Cara Therapeutics (CARA)
NASDAQ:CARA

Cara Therapeutics (CARA) Technical Analysis

2,206 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Cara Therapeutics’s (CARA) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Cara Therapeutics is a Buy.
Cara Therapeutics’s (CARA) 20-Day exponential moving average is 0.75, while Cara Therapeutics’s (CARA) share price is $0.671, making it a Sell.
Cara Therapeutics’s (CARA) 50-Day exponential moving average is 0.77, while Cara Therapeutics’s (CARA) share price is $0.671, making it a Sell.

Cara Therapeutics (CARA) Pivot Points

May 28, 2024, 10:33 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.58
0.63
0.68
0.73
0.78
0.83
0.88
Fibonacci
0.63
0.67
0.70
0.73
0.77
0.80
0.83
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cara Therapeutics (CARA) Moving Averages

May 28, 2024, 10:33 AM
Period
Simple
Exponential
MA5
0.73Sell
0.72Sell
MA10
0.74Sell
0.74Sell
MA20
0.75Sell
0.75Sell
MA50
0.78Sell
0.77Sell
MA100
0.74Sell
0.87Sell
MA200
1.16Sell
1.36Sell
Cara Therapeutics’s (CARA) 10-Day exponential moving average is 0.74, while Cara Therapeutics’s (CARA) share price is $0.671, making it a Sell.
Cara Therapeutics’s (CARA) 100-Day exponential moving average is 0.87, while Cara Therapeutics’s (CARA) share price is $0.671, making it a Sell.
Cara Therapeutics’s (CARA) stock price is $0.671 and Cara Therapeutics’s (CARA) 50-day simple moving average is 0.78, creating a Sell signal.
Cara Therapeutics’s (CARA) stock price is $0.671 and Cara Therapeutics’s (CARA) 100-day simple moving average is 0.74, creating a Sell signal.
Cara Therapeutics’s (CARA) stock price is $0.671 and Cara Therapeutics’s (CARA) 200-day simple moving average is 1.16, creating a Sell signal.

Cara Therapeutics (CARA) Technical Indicators

May 28, 2024, 10:33 AM
Name
Value
Implied Action
RSI (14)
40.00
Neutral
STOCH (9,6)
21.72
Neutral
STOCHRSI (14)
21.72
Neutral
MACD (12,26)
-0.01
Buy
ADX (14)
16.88
Buy
Williams %R
-100.00
Buy
CCI (14)
-196.24
Buy
ATR (14)
0.07
-
Ultimate Oscillator
30.42
Neutral
ROC
-15.19
Sell
Cara Therapeutics’s (CARA) Relative Strength Index (RSI) is 40.00, creating a Neutral signal.
Cara Therapeutics’s (CARA) Trend Strength Indicator (ADX) is 16.88, creating a Buy signal.
Cara Therapeutics’s (CARA) Commodity Channel Index (CCI) is -196.24, creating a Buy signal.
Cara Therapeutics’s (CARA) Price Rate of Change (ROC) is -15.19, creating a Sell signal.

FAQ

Is CARA a Buy, Hold, or Sell?
Based on CARA’s technical indicators, CARA is a Sell.
    What is CARA’s RSI (14)?
    CARA’s RSI (14) is 40.00, which suggests CARA is a Neutral.
      What is CARA’s MACD?
      CARA’s MACD is -0.01, which suggests CARA is a Buy.
        What is CARA’s 5-day moving average?
        CARA’s 5-day moving average is 0.73, which suggests CARA is a Sell.
          What is CARA’s 20-day moving average?
          CARA 20-day moving average is 0.75, which suggests CARA is a Sell.
            What is CARA’s 50-day moving average?
            CARA’s 50-day moving average is 0.78, which suggests CARA is a Sell.
              What is CARA’s 200-day moving average?
              CARA’s 200-day moving average is 1.16, which suggests CARA is a Sell.
                What is CARA’s Williams % R (14)?
                CARA’s Williams % R (14) is -100.00, which suggests CARA is a Buy.
                  What is CARA’s CCI (14)?
                  CARA’s CCI (14) is -196.24, which suggests CARA is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis